Industry News
9 in 10 don't link alcohol and cancer
4/01/2016
Almost 90 per cent of people in England don't associate drinking alcohol with an increased risk of cancer, according to a new report commissioned by Cancer Research UK published today (Friday).
Daily coffee, even decaf, may protect against colorectal cancer
4/01/2016
Drinking coffee every day, even decaffeinated coffee, may reduce the risk of colorectal cancer by up to 50%, according to a new study.
Thunderous rock music improves cancer drug delivery
4/01/2016
Rock music is being used to maximise the efficiency of cancer drug delivery.
Designing gene therapy
4/01/2016
Scientists at EMBL have increased the efficiency of a genome-engineering tool called Sleeping Beauty, which is showing promise in clinical trials of therapies for leukaemia and lymphoma.
Researchers in the group of Prof. Dr. Peter Vandenabeele (VIB/UGent) show that killed tumour cells can serve as a potent vaccine that stimulates the immune system to prevent the outgrowth of cancer...
Study highlights importance of expanding genetic testing for breast cancer patients
4/01/2016
Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, working in collaboration with researchers from the Harvard Medical School, today announced that the Journal of...
Brain cancer: Two essential amino acids might hold key to better outcomes
4/01/2016
The altered metabolism of two essential amino acids helps drive the development of the most common and lethal form of brain cancer, according to a new study led by researchers at The Ohio State...
Zika test for donated blood given green light by FDA
4/01/2016
The FDA have given the go-ahead for an experimental test for Zika to be used for screening blood donations, but they say deferment of exposed donors should remain for now.
Prostate-specific antigen screening publications influence biopsy rates and associated complications
4/01/2016
While absolute rates of biopsy and post-biopsy complications have decreased following several benchmark prostate-specific antigen (PSA) screening publications, the relative risk for each patient...
TGen and Mayo Clinic scientists issue report in Cell on advances in basal cell carcinoma
4/01/2016
Drugs target the Hedgehog cellular pathway to attack the nation's most common skin cancer, affecting nearly 2.8 million Americans each year.